As of 09 December, Operation Warp Speed (OWS) has purchased 800 million COVID-19 vaccine doses for the U.S.. This includes: 300M doses of the AstraZeneca/Oxford vaccine candidate, 100M doses of the Novavax candidate, 100M doses of the Pfizer/BioNTech candidate, 100M doses of the Sanofi/GSK candidate, 100M doses of the Johnson & Johnson candidate, and 100M doses of the Moderna candidate. The most recent purchase by OWS occurred on 11 August 2020. OWS is a public-private partnership by the U.S. government with the aim of facilitating and accelerating the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

What will be the total number of COVID-19 vaccine doses purchased by the U.S. as of 30 June 2021?

The OWS “Fact Sheet,” page, which is regularly updated, will be consulted at the end of the day on 30 June 2021. If this page is no longer regularly updated, then the most recent public announcement by OWS will be considered. For resolution, all of the vaccine doses that have been announced to be purchased for the U.S. up until 30 June 2021 will be added up. If a purchase agreement announcement uses the “at least” terminology, then the lowest number of vaccine doses will be considered — for instance, on 21 May OWS announced it had made a purchase to secure “at least” 300 million doses of the AstraZeneca/Oxford for the U.S. and this question will consider this to be a total of 300 million doses of said vaccine.